Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 279 followers
Latest posts
Last updated about 2 hours ago
AstraZeneca cans phase 2 opioid use disorder drug over interaction with common antifungal med
about 2 hours ago
AstraZeneca cans phase 2 opioid use disorder drug over interaction with common...
Neurogene reports death of Rett patient left in critical condition by high dose of gene therapy
about 3 hours ago
Neurogene reports death of Rett patient left in critical condition by high...
Flagship-backed Sonata says sayonara to CEO, trims crew by 20 staffers
about 17 hours ago
Flagship-backed Sonata says sayonara to CEO, trims crew by 20 staffers dincorvaia...
Philips raises curtain on next-gen helium-sealed MRI scanner
about 17 hours ago
Philips raises curtain on next-gen helium-sealed MRI scanner chale Thu, 11/21/2024 -...
Pyxis' shares tumble after early ADC readout in solid tumors fails to spark inspiration: analyst
about 18 hours ago
Pyxis' shares tumble after early ADC readout in solid tumors fails to...
Versant unveils Pep2Tango, a next-gen peptide biotech hoping to redefine obesity treatment
about 20 hours ago
Versant unveils Pep2Tango, a next-gen peptide biotech hoping to redefine obesity treatment...
After ProfoundBio buy, Genmab open to more M&A if it makes 'strategic sense,’ CFO says
about 21 hours ago
After ProfoundBio buy, Genmab open to more M&A if it makes 'strategic...
Enveda raises $130M series C to take more AI-discovered compounds into the clinic
about 21 hours ago
Enveda raises $130M series C to take more AI-discovered compounds into the...
BD teams up with MD Anderson, Su Clinica to study HPV self-collection tests in underserved Texas communities
about 21 hours ago
BD teams up with MD Anderson, Su Clinica to study HPV self-collection...
Kyowa Kirin fronts $330M to share rights to Kura's leukemia drug ahead of push to FDA
about 23 hours ago
Kyowa Kirin fronts $330M to share rights to Kura's leukemia drug ahead...
Novartis, assessing peers’ muscular dystrophy failures, pens $1.1B deal for gene therapy biotech
1 day ago
Novartis, assessing peers’ muscular dystrophy failures, pens $1.1B deal for gene therapy...
Novartis ‘took data to heart’ before slimming clinical pipeline by 40%, says CEO
1 day ago
Novartis ‘took data to heart’ before slimming clinical pipeline by 40%, says...